trending Market Intelligence /marketintelligence/en/news-insights/trending/BXqZqVaemKYILDb5yXimzQ2 content esgSubNav
In This List

Sofinnova Partners closes VC fund at €333M

Blog

Balance Sheet Strategy in an Unusual Rate Environment

Blog

Investors' Views of the Industry Today & the Outlook for Tomorrow

Podcast

Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion


Sofinnova Partners closes VC fund at €333M

Sofinnova Partners raised €333 million for its latest healthcare venture capital fund.

Sofinnova Capital IX will target the biopharmaceutical and medical device sectors. Two-thirds of the investments will be placed in European companies and a third in companies outside of Europe, primarily in North America.

Triago acted as placement agent, while Clifford Chance was the legal counsel.

Sofinnova Partners specializes in life sciences and makes investments across development stages.